JUBILANT INGREVIA LIMITED Fair Value
JUBLINGREA · Chemicals · Current price ₹693.35
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹188 | 10% ROE fading to 13% over ~3 yrs, on ₹196 book |
| Relative P/E | ₹789 | EPS × 45.2 peer-median P/E |
| Graham floor | ₹277 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹967 | Street consensus 12-month target price |
Is JUBILANT INGREVIA LIMITED undervalued?
DocStoX estimates the fair value of JUBILANT INGREVIA LIMITED at ₹464 per share, versus the current market price of ₹693. That puts the stock about -33.1% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹188), Relative P/E (₹789), Graham floor (₹277), Analyst target (₹967). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹188 (bear) to ₹464 (base) to ₹967 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on JUBILANT INGREVIA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.